RAPT Therapeutics, Inc.
RAPT
$11.32
$0.5955.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.39% | -9.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.40% | -64.63% | |||
| Operating Income | -1.40% | 64.63% | |||
| Income Before Tax | -2.78% | 67.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.78% | 67.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.78% | 67.76% | |||
| EBIT | -1.40% | 64.63% | |||
| EBITDA | -1.55% | 64.91% | |||
| EPS Basic | -2.70% | 93.01% | |||
| Normalized Basic EPS | 1.28% | 92.80% | |||
| EPS Diluted | -2.70% | 93.01% | |||
| Normalized Diluted EPS | 1.28% | 92.80% | |||
| Average Basic Shares Outstanding | 0.09% | 361.39% | |||
| Average Diluted Shares Outstanding | 0.09% | 361.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||